Simon Murray, MD

Dr. Simon Murray reflects on the ongoing fight against cardiovascular disease in the US as part of our coverage of American Heart Month.

In the last of our 3-part series examining the idea of a cardiometabolic subspecialty, Simon Murray, MD, offers his thoughts on who should be treating patients with type 2 diabetes.

Can positive ELISA test results better interpret for how much longer social distancing must continue?

What is the role of ACE inhibition or angiotensin receptor blockers (ARBs) within regard to the novel coronavirus (COVID-19)?

A study’s proposed findings of increased coronavirus risk shows how presenting half of a fact can influence our care during a pandemic.

The newest virus scare has killed one-tenth as many patients as influenza this season, yet public concern fixates on the smaller issue.

Doctors are prone to workplace gaffes like anyone else. Here's a list of the funniest ones yet.

The suggestion that DECT scans might add to our diagnostic ability to detect cardiac disease may be imprudent because we have tests at our disposal and have little need to increase diagnostic costs. Good clinical judgement, paying attention to traditional risk factors and to red flags, will increase the number of asymptomatic cardiac patients we choose to study with conventional methods.

Why implementing regimented care may be more complicated than setting the rule in the first place.

The differences between thoughtful and intuitive decision-making, and how it shapes patient care.

Among the year's most noteworthy findings in rheumatology, includes a systemic review and meta-analysis that provides a better understanding of how common infections and cancer really are in patients treated with interleukin (IL) inhibitors. In this article, Dr. Murray offers his personal perspectives on the findings.

Over 4 decades, the lessons I learned from my first chief of medicine have never wavered in value.

As I prepare for my Thanksgiving meal, I’m struck by the number of CPT codes that physicians may have to use this season.

Prior to the start of HFSA, Dr. Murray dives through how the extensive history of heart failure research has lead to today's greatest cardiovascular breakthroughs.

Marketed sunscreen in the US is a bit more regulated than in other countries. But are those regulations helpful?

Measles cases in the US have reached 700 this year, but the true threat is those who willingly exempt their children from the vaccination.

Concierge medical practices are trending upward, and proving beneficial for patients. It's time for standard physicians to reassess their practice.

It's been nearly a century since one of the greatest medical findings reached patients. How has the story of insulin changed modern diabetes care?

Time-restricted feeding has been shown in early trials to be a beneficial treatment for various cardiovascular disease risk metrics.

A speech from former US Surgeon General Vivek H. Murthy, MD, gave hope to a room full of physicians that positive change is still possible.

At ACP, physicians came together to tell their stories of what keeps them going in medicine. There's a unifying message in all of them.

Five years ago, I held in my hands a formalin-filled jar containing several fragments of grey tissue wrapped in gauze—the last remains of last century's greatest genius.

Overconfidence, anchoring errors, biases, and other factors have all led to misdiagnoses at points in my internal medicine career.

A short account of patients I’ve known and not loved over the years.

How I became a doctor, lost sight of the joy of practice, and eventually regained my passion to serve my patients.

Onychomycosis—fungal infection of the nail—is a common medical problem. Treatments are widely available, but relapse is common.

Recommendations for acne treatment drawn from AAD position paper and presentations.

An internist’s perspective on which sessions to attend, from melanoma to inflammatory diseases to cosmetic procedures.

Do higher scores alone predict success in medical school, or in clinical practice?

Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.